Analysts’ Top Healthcare Picks: Synthetic Biologics Inc (SYN), La Jolla Pharma (LJPC)


There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Synthetic Biologics Inc (NYSE:SYN) and La Jolla Pharma (NASDAQ:LJPC) with bullish sentiments.

Synthetic Biologics Inc (SYN)

H.C. Wainwright analyst Edward White maintained a Buy rating on Synthetic Biologics Inc today and set a price target of $1. The company’s shares opened today at $0.13, close to its 52-week low of $0.10.

White said:

“We base our $1 price target on probability-adjusted revenue forecasts for ribaxamase in the prevention of CDI and SYN-010 for the treatment of IBS-C. We use the net present value of our revenue forecast through 2028, apply a 35% probability of success (POS) for ribaxamase in CDI, a 25% POS for the early stage pipeline, and a 3x price/sales multiple to arrive at our $1 price target.”

According to TipRanks.com, White is a 5-star analyst with an average return of 25.7% and a 55.7% success rate. White covers the Healthcare sector, focusing on stocks such as Syndax Pharmaceuticals Inc, Spectrum Pharmaceuticals, and Karyopharm Therapeutics.

Synthetic Biologics Inc has an analyst consensus of Moderate Buy, with a price target consensus of $1.

See today’s analyst top recommended stocks >>

La Jolla Pharma (LJPC)

SunTrust Robinson analyst Yatin Suneja reiterated a Buy rating on La Jolla Pharma today and set a price target of $45. The company’s shares opened today at $31.

According to TipRanks.com, Suneja is a 3-star analyst with an average return of 4.6% and a 48.5% success rate. Suneja covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, Seattle Genetics, and Agios Pharma.

La Jolla Pharma has an analyst consensus of Moderate Buy, with a price target consensus of $59.40, representing a 91.6% upside. In a report issued on July 27, H.C. Wainwright also maintained a Buy rating on the stock with a $53 price target.

.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts